H.C. Wainwright Starts Generate Biomedicines (GENB) at Buy
Tweet
Share
E-mailGet Alerts GENB Hot Sheet
Price: $16.46 -2.43%
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 10 | New: 23
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 10 | New: 23
Join SI Premium – FREE
H.C. Wainwright initiates coverage on Generate Biomedicines (NASDAQ: GENB) with a Buy rating and a price target of $16.00.
For an analyst ratings summary and ratings history on Generate Biomedicines click here. For more ratings news on Generate Biomedicines click here.
Shares of Generate Biomedicines closed at $11.41 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- US's Greer Says Usmca Shifting To Rolling Talks, No Renewal - Bloomberg
- Who wins if the US restricts Chinese solar inverters?
- AMD (AMD) call put ratio 1.4 calls to 1 put as share price down 4.3%
Create E-mail Alert Related Categories
New CoverageRelated Entities
Maynard Um, H.C. Wainwright, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
